Prelay en es it fr

Prelay Brand names, Prelay Analogs

Prelay Brand Names Mixture

  • No information avaliable

Prelay Chemical_Formula


Prelay RX_link

Prelay fda sheet

Prelay FDA

Prelay msds (material safety sheet)

Prelay Synthesis Reference

No information avaliable

Prelay Molecular Weight

441.541 g/mol

Prelay Melting Point

184-186 oC

Prelay H2O Solubility

No information avaliable

Prelay State


Prelay LogP

No information avaliable

Prelay Dosage Forms

No information avaliable

Prelay Indication

For the treatment of Type II diabetes mellitus

Prelay Pharmacology

Troglitazone is an oral antihyperglycemic agent which acts primarily by decreasing insulin resistance. Troglitazone is used in the management of type II diabetes (noninsulin-dependent diabetes mellitus (NIDDM) also known as adult-onset diabetes). It improves sensitivity to insulin in muscle and adipose tissue and inhibits hepatic gluconeogenesis. Troglitazone is not chemically or functionally related to either the sulfonylureas, the biguanides, or the g-glucosidase inhibitors. Troglitazone may be used concomitantly with a sulfonylurea or insulin to improve glycemic control.

Prelay Absorption

Absorbed rapidly. Food increases the extent of absorption by 30% to 85%.

Prelay side effects and Toxicity

No information avaliable

Prelay Patient Information


Follow the links

Prelay Organisms Affected

Humans and other mammals